Answers - Finance

No transactions were reported for the week ending February 9, according to Nuclear Market Review (NMR). As a result, the TradeTech spot uranium price

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

indicator remained unchanged at US$75/pound. “Market participants are focused on the upcoming auction by a U.S. uranium producer,” wrote NMR editor Tr

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

va Klingbiel. She explained approximately 100 thousand pounds of U3O8 could be offered for sale by the end of February.

During this past week, sever

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

al buyers submitted bids for 208 thousand pounds of U3O8 to a single seller. The U3O8, contained in an enriched uranium product, had been previously o

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

fered to the market. According to NMR, the seller “is now evaluating” those bids.

“There is going to be upward pressure on prices,” TradeTech chief e

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

xecutive Gene Clark told StockInterview. While uranium buyers want to lock in fixed price contracts, sellers want to be paid the going rate at the ‘ti

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

e of delivery.’ Because sellers expect rising prices in the months ahead, “a significant gap exists” between them,” Clark told us.

Despite a quiet we

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

ek absent any transactions or new demand, the existing demand remained firm. Klingbiel wrote, “15 utilities (are) currently evaluating offers or seeki

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

g to purchase almost 54 million pounds” in the long-term uranium market. Nine buyers continue to collectively seek 4.5 million pounds U3O8 equivalent.

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

But Klingbiel also cautioned, “Approximately one-half of this demand is discretionary.”

While no transactions were reported in the conversion or enr

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

chment markets, utilities are evaluating offers and sellers are evaluating bids in both markets. For example, one U.S. utility continues to evaluate o

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

ffers received in January for delivery of almost 3 million SWU; another is evaluating December offers for 1 million SWU. Long-term SWU remains at US$1

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

7.

Year-to-date (YTD) transaction volume is seasonally slow, but more quiet than usual. Over the past twelve years, YTD transaction volumes were high

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

er, by early February, than in any other year except 1997.

TradeTech, through its predecessor NUEXCO, was the first organization to publish uranium p

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

ices, beginning in August 1968. After publishing the spot and long-term uranium price in Nuclear Market Review, TradeTech reports the weekly spot uran

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

ium indicator on the consulting service’s website.

Timing is everything for many of the junior uranium companies, and the timing of the next spot ura

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

ium auction may not get better than this. Many juniors hope to showcase their company’s developments and future plans at the annual PDAC Convention, o

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

ften issuing their strongest news before the event commences.

This is the Diamond Anniversary event, being held in Toronto and starting March 4th. Fo

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

75 years, prospectors and developers have met to exchange stories, gossip and plans for the coming year. Teck Cominco (NYSE: TCK) is the diamond spon

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.answers.org.ua/article/102243/answers-Next-Auction-Could-Send-Uranium-Higher.html">Next Auction Could Send Uranium Higher</a>

BB link (for phorums):
[url=http://www.answers.org.ua/article/102243/answers-Next-Auction-Could-Send-Uranium-Higher.html]Next Auction Could Send Uranium Higher[/url]

In the past few years, more and more stay at home jobs have cropped up. And at this pace, more and more will tomorrow.

Imagine having your own Web-crawling robot, surfing the Internet 24/7 to find relevant information you can use in your blog. Think of the time you would save, having this content delivered to your inbox every day. How much would a robot like that be worth? How about free?

Most people just don't get it when it comes to email marketing. They think they can blast someone with information and just list features and benefits and that person will magically convert into a sale. Well... they're wrong. Unless you understand...

Tags

Links

Answers - Next Auction Could Send Uranium Higher

Related Articles: